(Q42280169)

19 October 2017

title

Mechanism of inhibition of human nonpancreatic secreted phospholipase A2 by the anti-inflammatory agent BMS-181162. (English)

1 reference

19 October 2017

J R Burke

1

1 reference

19 October 2017

K R Gregor

series ordinal

2

1 reference

19 October 2017

K M Tramposch

series ordinal

3

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

Journal of Biological Chemistry

19 October 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 October 2017

volume

270

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

274-280

1 reference

Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

The primary structure of a membrane-associated phospholipase A2 from human spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Phospholipase A2 from human synovial fluid: purification and structural homology to the placental enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Phospholipase A2 is a major component of the salt-extractable pool of matrix proteins in adult human articular cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

The divalent cation is obligatory for the binding of ligands to the catalytic site of secreted phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Interfacial catalysis by phospholipase A2: determination of the interfacial kinetic rate constants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Novel inhibitor of phospholipase A2 with topical anti-inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Phospholipase A2-catalyzed hydrolysis of vesicles: uses of interfacial catalysis in the scooting mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Competitive inhibition of phospholipase A2 in vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

The kinetics of interfacial catalysis by phospholipase A2 and regulation of interfacial activation: hopping versus scooting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Interfacial catalysis by phospholipase A2: dissociation constants for calcium, substrate, products, and competitive inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Action of phospholipase A2 on bilayers. Effect of inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Assay of phospholipases A(2) and their inhibitors by kinetic analysis in the scooting mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

N-(carboxymethyl)-N-[3,5-bis(decyloxy)-phenyl]glycine (Ro 23-9358): a potent inhibitor of secretory phospholipases A2 with antiinflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Relationship of interfacial equilibria to interfacial activation of phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Fatty acid amides: scooting mode-based discovery of tight-binding competitive inhibitors of secreted phospholipases A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Methylation of histidine-48 in pancreatic phospholipase A2. Role of histidine and calcium ion in the catalytic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Isolation and Characterization of cDNA Clones from Human Placenta Coding for Phospholipase A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Kinetics of interfacial catalysis by phospholipase A2 in intravesicle scooting mode, and heterofusion of anionic and zwitterionic vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Human nonpancreatic secreted phospholipase A2: interfacial parameters, substrate specificities, and competitive inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Solute diffusion in lipid bilayer membranes: an atomic level study by molecular dynamics simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Active-site-directed specific competitive inhibitors of phospholipase A2: novel transition-state analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

Histidine at the active site of phospholipase A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.1.274

21 January 2018

Identifiers

DOI

10.1074/JBC.270.1.274

1 reference

19 October 2017

1 reference